Global Research Collaboration As the internationally recognized cancer research agency of the World Health Organization, IARC collaborates with over 100 countries through initiatives like the Global Summit on Traditional Medicine. This widespread engagement presents opportunities to offer advanced research tools, data analytics, and digital health solutions to strengthen their collaborative efforts.

Innovation in Vaccine Development The recent launch of the human avian influenza vaccine using technology similar to COVID-19 vaccines indicates a focus on cutting-edge biotechnologies. This highlights a potential market for biotech IT solutions, clinical trial management platforms, and vaccine manufacturing analytics services to support their innovative projects.

Strategic Digital Health Focus With the launch of the Global Strategy on Digital Health and partnerships like the Learning on TAP platform, IARC demonstrates a commitment to digital transformation in healthcare. There are opportunities to provide digital health platforms, telemedicine solutions, and data security services tailored to their strategic initiatives.

Funding and Scale Operating with a revenue range of 50 to 100 million dollars and a sizable employee base, IARC presents a solid opportunity for scalable B2G sales in research infrastructure, data management systems, and analytic tools that can efficiently support their extensive research and outreach programs.

Research and Analytical Technolog​​y Given their active use of tools such as Tableau, Cvent, and HTML, IARC is invested in data visualization and event management. This provides a foothold for offering advanced BI platforms, virtual event solutions, and scientific data dissemination tools to enhance their research communication and collaboration capabilities.